These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 1563114

  • 1. Membranous nephropathy with graft-versus-host disease in a bone marrow transplant recipient.
    Barbara JA, Thomas AC, Smith PS, Gillis D, Ho JO, Woodroffe AJ.
    Clin Nephrol; 1992 Mar; 37(3):115-8. PubMed ID: 1563114
    [Abstract] [Full Text] [Related]

  • 2. [A case of nephrotic syndrome after bone marrow transplantation].
    Yabana M, Takagi N, Kihara M, Muto R, Tamura K, Maemoto S, Minamisawa M, Nakatani Y, Ishii M.
    Nihon Jinzo Gakkai Shi; 1997 May; 39(4):414-20. PubMed ID: 9198364
    [Abstract] [Full Text] [Related]

  • 3. Nephrotic syndrome in a bone marrow transplant recipient with chronic graft-versus-host disease.
    Sato N, Kishi K, Yagisawa K, Kasama J, Karasawa R, Shimada H, Nishi S, Ueno M, Ito K, Koike T.
    Bone Marrow Transplant; 1995 Aug; 16(2):303-5. PubMed ID: 7581152
    [Abstract] [Full Text] [Related]

  • 4. Antineutrophil cytoplasmic antibody-associated glomerulonephritis in chronic graft-versus-host disease after allogenic hematopoietic stem cell transplantation.
    Nouri-Majelan N, Sanadgol H, Ghafari A, Rahimian M, Najafi F, Mortazavizadeh M, Moghaddasi S.
    Transplant Proc; 2005 Sep; 37(7):3213-5. PubMed ID: 16213351
    [Abstract] [Full Text] [Related]

  • 5. Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
    Gallardo D, García-López J, Sureda A, Canals C, Ferra C, Cancelas JA, Berlanga JJ, Brunet S, Boqué C, Picón M, Torrico C, Amill B, Martino R, Martínez C, Martín-Henao G, Domingo-Albós A, Grañena A.
    Bone Marrow Transplant; 1997 Dec; 20(11):945-52. PubMed ID: 9422473
    [Abstract] [Full Text] [Related]

  • 6. Passive donor-to-recipient transfer of antiphospholipid syndrome following allogeneic stem-cell transplantation.
    Ritchie DS, Sainani A, D'Souza A, Grigg AP.
    Am J Hematol; 2005 Aug; 79(4):299-302. PubMed ID: 16044450
    [Abstract] [Full Text] [Related]

  • 7. Nephrotic syndrome as a clinical manifestation of graft-versus-host disease (GVHD) in a marrow transplant recipient after cyclosporine withdrawal.
    Oliveira JS, Bahia D, Franco M, Balda C, Stella S, Kerbauy J.
    Bone Marrow Transplant; 1999 Jan; 23(1):99-101. PubMed ID: 10037059
    [Abstract] [Full Text] [Related]

  • 8. Graft-versus-leukemia in bone marrow transplantation. The Advisory Committee of the International Bone Marrow Transplant Registry.
    Gale RP, Horowitz MM.
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():94-7. PubMed ID: 2390646
    [Abstract] [Full Text] [Related]

  • 9. Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease.
    Aschan J, Ringdén O.
    Clin Transplant; 1994 Jun; 8(3 Pt 1):258-70. PubMed ID: 8061365
    [Abstract] [Full Text] [Related]

  • 10. [Successful treatment of recurrent chronic myelogenous leukemia in allogeneic marrow transplant recipient with the donor leukocyte transfusion, without induction of acute graft-versus-host disease].
    Yamazaki H, Nakao S, Takamatsu H, Ito T, Ueda M, Shiobara S, Matsuda T.
    Rinsho Ketsueki; 1995 Jul; 36(7):677-81. PubMed ID: 7563596
    [Abstract] [Full Text] [Related]

  • 11. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
    Naparstek E, Nagler A, Or R, Kapelushnik J, Slavin S.
    Clin Transpl; 1996 Jul; ():281-90. PubMed ID: 9286578
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Eradication of adult T-cell leukemia cells and maintenance of remission by the graft-versus-leukemia effect after allogeneic bone marrow transplantation].
    Ota K, Hashino S, Shimizu K, Yonezumi M, Chiba K, Kondo T, Suzuki S, Imamura M, Asaka M.
    Rinsho Ketsueki; 2004 Sep; 45(9):1044-7. PubMed ID: 15510833
    [Abstract] [Full Text] [Related]

  • 14. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
    Weiss L, Lubin I, Factorowich I, Lapidot Z, Reich S, Reisner Y, Slavin S.
    J Immunol; 1994 Sep 15; 153(6):2562-7. PubMed ID: 8077666
    [Abstract] [Full Text] [Related]

  • 15. [Nephrotic syndrome related to chronic graft versus host disease after allogeneic bone marrow transplantation in a patient with malignant lymphoma].
    Haseyama K, Watanabe J, Oda T, Katoh S, Suzuki N, Kudoh T, Chiba S.
    Rinsho Ketsueki; 1996 Dec 15; 37(12):1383-8. PubMed ID: 8997126
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Acute graft-versus-host disease after bone marrow transplantation with a single HLA-DPB1*1001 mismatch: involvement of different TCRBV subsets.
    Gaschet J, Gallot G, Ibisch C, Lim A, Even J, Vivien R, Hallet MM, Milpied N, Vié H.
    Bone Marrow Transplant; 1998 Aug 15; 22(4):385-92. PubMed ID: 9722075
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Allogeneic marrow transplantation in patients with chronic myeloid leukemia in chronic phase following preparation with busulfan and cyclophosphamide.
    Galimberti M, Polchi P, Lucarelli G, Angelucci E, Baronciani D, Giardini C, Gaziev D, Erer B, Ripalti M, Rapa S.
    Bone Marrow Transplant; 1994 Feb 15; 13(2):197-201. PubMed ID: 8205089
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.